StockDrifts LogoStockDrifts

Genolution 225220

Company
제놀루션Genolution
Insiders
4
Buys
35
Total Value
₩93M ($64K)
Avg Return
-19.81%
Last Filing
2026-07-01

Genolution (225220) has 35 disclosed insider purchases and 0 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩93M ($64K) in reported transaction value. The earliest filing StockDrifts holds for Genolution is dated 2023-04-24; the most recent is 2026-07-01. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -19.81%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-12BUYMarket Buy
김기옥
Kim Ki-ok
CEO15.0K₩1,445-4.8%₩21M ($14K)
2026-08-11BUYMarket Buy
김기옥
Kim Ki-ok
CEO10.9K₩1,417-3.0%₩15M ($10K)
2026-08-10BUYMarket Buy
김기옥
Kim Ki-ok
CEO11.0K₩1,409-2.4%₩15M ($10K)
2026-08-07BUYMarket Buy
김기옥
Kim Ki-ok
CEO12₩1,330+3.4%₩16K ($11)
2026-07-23BUYMarket Buy
김민이
Kim Min-i
CEO6.0K₩1,305-0.1%₩8M ($5K)
2026-07-22BUYMarket Buy
김민이
Kim Min-i
CEO2.9K₩1,293+0.8%₩4M ($3K)
2026-07-21BUYMarket Buy
김민이
Kim Min-i
CEO1.3K₩1,289+1.2%₩2M ($1K)
2026-07-15BUYMarket Buy
김민이
Kim Min-i
CEO3.0K---
2026-07-14BUYMarket Buy
김민이
Kim Min-i
CEO5.0K---
2026-07-01BUYMarket Buy
김민이
Kim Min-i
CEO7.5K---
2026-06-30BUYMarket Buy
김민이
Kim Min-i
CEO6.0K---
2026-06-29BUYMarket Buy
김민이
Kim Min-i
CEO10.0K---
2026-06-29BUYMarket Buy
김우진
Woojin Kim
Managing Director4.4K---
2026-06-26BUYMarket Buy
김민이
Kim Min-i
CEO4.1K---
2026-06-24BUYMarket Buy
김민이
Kim Min-i
CEO7.0K---
2026-06-23BUYMarket Buy
김민이
Kim Min-i
CEO7.2K---
2026-06-12BUYMarket Buy
김민이
Kim Min-i
CEO6.8K---
2026-06-11BUYMarket Buy
김민이
Kim Min-i
CEO6.7K---
2026-06-10BUYMarket Buy
김민이
Kim Min-i
CEO7.7K---
2026-06-09BUYMarket Buy
김민이
Kim Min-i
CEO2.7K---
2026-06-09BUYMarket Buy
김우진
Woojin Kim
Managing Director1.0K---
2026-06-08BUYMarket Buy
김우진
Woojin Kim
Managing Director3.0K---
2026-06-08BUYMarket Buy
김민이
Kim Min-i
CEO6.5K---
2026-04-09BUYMarket Buy
김민이
Kim Min-i
CEO6.6K₩1,790+10.6%₩12M ($8K)
2026-04-08BUYMarket Buy
김민이
Kim Min-i
CEO7.0K₩1,790+10.6%₩13M ($9K)
2026-04-07BUYMarket Buy
김민이
Kim Min-i
CEO7.2K₩1,790+10.6%₩13M ($9K)
2026-04-06BUYMarket Buy
김민이
Kim Min-i
CEO5.5K₩1,809+9.4%₩10M ($7K)
2026-03-19BUYMarket Buy
김민이
Kim Min-i
CEO2.0K---
2026-03-18BUYMarket Buy
김민이
Kim Min-i
CEO8.4K---
2026-03-17BUYMarket Buy
김민이
Kim Min-i
CEO6.8K---
2026-03-16BUYMarket Buy
김민이
Kim Min-i
CEO8.1K---
2026-03-12BUYMarket Buy
김민이
Kim Min-i
CEO4.7K---
2026-03-09BUYMarket Buy
김기옥
Kim Ki-ok
CEO16.0K---
2026-03-06BUYMarket Buy
김기옥
Kim Ki-ok
CEO10.0K---
2026-03-05BUYMarket Buy
김기옥
Kim Ki-ok
CEO3.7K---
2026-02-20BUY자사주상여금
신희종
Heejong Shin
moving1.5K₩1,810-0.6%₩3M ($2K)
2026-02-20BUY자사주상여금
김우진
Woojin Kim
Managing Director5.3K₩1,810-0.6%₩10M ($7K)
2025-12-29BUY장외매수
김기옥
Kim Ki-ok
CEO190.0K₩1,930-6.7%₩367M ($255K)
2025-12-29SELL장외매도
호일바이오메드
Hoyl Biomed
--190.0K₩1,930+6.7%₩367M ($255K)
2025-02-21BUY자사주상여금
김우진
Woojin Kim
Managing Director5.3K₩2,660-32.3%₩14M ($10K)
2025-02-21BUY자사주상여금
신희종
Heejong Shin
moving1.5K₩2,660-32.3%₩4M ($3K)
2025-01-21BUYMarket Buy
김민이
Kim Min-i
Managing Director5.5K₩2,640-31.8%₩14M ($10K)
2025-01-21BUYMarket Buy
KimSangHoon
vice president2.0K₩2,640-31.8%₩5M ($4K)
2025-01-21BUYMarket Buy
김우진
Woojin Kim
Managing Director1.0K₩2,640-31.8%₩3M ($2K)
2025-01-20BUYMarket Buy
김우진
Woojin Kim
Managing Director1.0K₩2,715-33.7%₩3M ($2K)
2025-01-20BUYMarket Buy
김민이
Kim Min-i
Managing Director2.0K₩2,715-33.7%₩5M ($4K)
2025-01-17BUYMarket Buy
김우진
Woojin Kim
Managing Director1.0K₩2,770-35.0%₩3M ($2K)
2025-01-17BUYMarket Buy
김민이
Kim Min-i
Managing Director2.5K₩2,770-35.0%₩7M ($5K)
2025-01-17BUYMarket Buy
KimSangHoon
vice president1.0K₩2,770-35.0%₩3M ($2K)
2025-01-15BUYMarket Buy
KimSangHoon
vice president1.0K₩2,595-30.6%₩3M ($2K)

Showing the 50 most recent of 53 filings.

Frequently asked questions

Who has been buying Genolution stock?
4 distinct insiders have filed 35 disclosed insider purchases in Genolution (225220), most recently on 2026-07-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Genolution have?
Genolution has 35 buy-side and 0 sell-side disclosures on record, covering ₩93M ($64K) in total reported value, spanning 2023-04-24 to 2026-07-01.
Where does StockDrifts get Genolution insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Genolution. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.